Gacang, Kate .
HRN: 28-36-89 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/07/2026
MEBENDAZOLE 100MG/5ML, 60ML SUSPENSION
01/07/2026
01/10/2026
ORAL
5ml
BID
Intestinal Parasitic Infection
Checking Final Appropriateness
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes